Multiple Myeloma Breakthrough: CAR-T Therapy Now Approved as Second-Line Treatment in Italy
For patients battling multiple myeloma, the timing of treatment is often as critical as the treatment itself. For years, the most advanced weapon in the oncological arsenal—CAR-T cell therapy—was reserved as a “last resort,” administered only after patients had failed multiple rounds of chemotherapy, proteasome inhibitors and stem cell transplants. However, a significant shift in … Read more
